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Insulin stimulation of target cells elicits a burst of H2O2 that enhances tyrosine phosphorylation of the
insulin receptor and its cellular substrate proteins as well as distal signaling events in the insulin action
cascade. The molecular mechanism coupling the insulin receptor with the cellular oxidant-generating appa-
ratus has not been elucidated. Using reverse transcription-PCR and Northern blot analyses, we found that
Nox4, a homolog of gp91phox, the phagocytic NAD(P)H oxidase catalytic subunit, is prominently expressed in
insulin-sensitive adipose cells. Adenovirus-mediated expression of Nox4 deletion constructs lacking NAD(P)H
or FAD/NAD(P)H cofactor binding domains acted in a dominant-negative fashion in differentiated 3T3-L1
adipocytes and attenuated insulin-stimulated H2O2 generation, insulin receptor (IR) and IRS-1 tyrosine
phosphorylation, activation of downstream serine kinases, and glucose uptake. Transfection of specific small
interfering RNA oligonucleotides reduced Nox4 protein abundance and also inhibited the insulin signaling
cascade. Overexpression of Nox4 also significantly reversed the inhibition of insulin-stimulated IR tyrosine
phosphorylation induced by coexpression of PTP1B by inhibiting PTP1B catalytic activity. These data suggest
that Nox4 provides a novel link between the IR and the generation of cellular reactive oxygen species that
enhance insulin signal transduction, at least in part via the oxidative inhibition of cellular protein-tyrosine
phosphatases (PTPases), including PTP1B, a PTPase that has been previously implicated in the regulation of
insulin action.
The elaboration of a large amount of cellular reactive oxy-
gen species by hematopoietic phagocytic cells is essential for
host defenses in bactericidal killing (1). However, more re-
cently it has been appreciated that low levels of cellular oxi-
dants, including superoxide and H2O2, are produced in a rapid
temporal response to cellular growth factor and cytokine stim-
ulation and are integral to the regulation of a variety of intra-
cellular signaling pathways (41). Cellular reactive oxygen spe-
cies have been shown to be elaborated in response to
epidermal growth factor, platelet-derived growth factor, trans-
forming growth factor , and other growth factors (2, 3, 22, 37,
41) as well as with insulin stimulation (29, 34, 35).
Insulin signaling is initiated by the phosphorylation of spe-
cific tyrosyl residues of the cell surface insulin receptor, which
activates its exogenous kinase activity and promotes the phos-
phorylation of IRS proteins on specific tyrosine residues (42).
Much of insulin’s downstream signaling to metabolic events
involves the activation of phosphatidylinositol (PI) 3-kinase
activity by the docking of its p85 subunit to tyrosine-phospho-
rylated IRS-1 and IRS-2, which is linked to a network of distal
signaling responses, including activation of protein kinase Akt
and the stimulation of glucose uptake and other metabolic
responses in specific cell types (23, 45). In parallel, insulin also
activates cellular growth pathways mediated by Erk mitogen-
activated protein kinases (MAPKs). In addition to these sig-
naling events, our investigators have recently demonstrated
that insulin stimulation of adipose and hepatoma cells leads to
the rapid generation of cellular reactive oxygen species that
facilitates both early and distal signal transduction through the
insulin action pathway (34, 35). The effect of insulin-stimulated
oxidant species is mediated at least in part via the oxidative
inhibition of cellular protein-tyrosine phosphatases (PTPases),
which depend on a reduced thiol moiety for catalytic activity
and are normally inhibitory to insulin signal transduction (19,
37). PTP1B, in particular, has been considered to be a major
candidate PTPase for the regulation of insulin action in a
variety of studies, including knockout mouse models (13, 18,
25).
The molecular components of the insulin-responsive oxi-
dant-generating activity in cell types that are targets for insulin
action have not been identified. Previous work has demon-
strated that the catalytic activity of the insulin-responsive sys-
tem has enzymatic characteristics consistent with an NAD(P)H
oxidase activity, catalyzing the reduction of molecular oxygen
to generate superoxide, which undergoes subsequent dismuta-
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tion to generate H2O2 (26–28, 38). The prototypic NAD(P)H
oxidase complex from phagocytic cells has been extensively
characterized. It consists of six subunits, including two plasma
membrane-associated proteins, gp91phox and p22phox, which
comprise flavocytochrome b558, and four cytosolic factors,
p47phox, p67phox, p40phox, and rac (1). The catalytic
gp91phox subunit (also now known as Nox2) contains C-ter-
minal homology to known flavoprotein dehydrogenases and
consensus sequences comprising a putative NAD(P)H binding
site (9, 39). Nox2 has recently been used in cloning studies to
identify a small family of five homologous Nox [NAD(P)H
oxidase] enzymes which are variably expressed in different tis-
sues (8, 30).
To initiate studies into the molecular mechanism of the
insulin-induced oxidant species in insulin-sensitive cells, in the
present work we first identified that Nox4 was a prominent
NAD(P)H oxidase catalytic subunit homolog expressed in ad-
ipose cells. Overexpression of wild-type Nox4 and Nox4 con-
structs lacking cofactor binding domains for NAD(P)H or
FAD/NAD(P)H using adenovirus-mediated gene delivery in
differentiated 3T3-L1 adipocytes revealed that the deletion
constructs function as dominant negatives and suppress insu-
lin-induced cellular oxidant generation and insulin signaling,
including tyrosine phosphorylation of the insulin receptor and
its substrate protein IRS-1, and attenuate the activation of
downstream signaling kinases as well as glucose uptake. In
parallel studies, reduction of Nox4 protein mass by transfec-
tion of specific small interfering RNA (siRNA) constructs also
resulted in inhibition of the insulin action cascade. Overexpres-
sion of Nox4 also significantly reversed the inhibition of insu-
lin-stimulated insulin receptor tyrosine phosphorylation in-
duced by coexpression of PTP1B by inhibiting the catalytic
activity of PTP1B. These data suggest that Nox4 provides a
novel link between the insulin receptor and the generation of
cellular reactive oxygen species that enhance insulin signal
transduction via the oxidative inhibition of cellular PTPases,
including PTP1B.
MATERIALS AND METHODS
Materials. Cell culture media and reagents were from Invitrogen (Carlsbad,
Calif.); serum was from HyClone (Logan, Utah). 3T3-L1 cells were originally
obtained from the American Type Culture Collection (Rockville, Md.). Human
simian virus 40 (SV40)-transformed microvascular endothelial (HADMEC-5)
cells (16) were a gift from John Flynn (Thomas Jefferson University). Human
subcutaneous and omental adipose tissues were obtained at surgery with proper
consent and procedures in accordance with the Institutional Review Board of
Thomas Jefferson University. siRNAs were purchased from Dharmacon (Lafay-
ette, Colo.). The Adeno-X expression system and rapid titer kit were from BD
Biosciences (Palo Alto, Calif.). Recombinant human insulin was obtained from
Sigma (St. Louis, Mo.). 5,6-Chloromethyl-2,7-dichlorodihydrofluorescein diac-
etate (CM-DCF-DA) was from Molecular Probes (Eugene, Oreg.); enhanced
chemiluminescence (ECL) reagents were from NEN Life Science Products (Bos-
ton, Mass.). Monoclonal antiphosphotyrosine (4G10) and polyclonal antibodies
to the insulin receptor -subunit, IRS-1, and the p85 subunit of PI 3-kinase were
from Upstate Biotechnology (Lake Placid, N.Y.). Antibodies to phosphorylated
Akt (Ser473) and Akt protein (not isoform specific) and phospho-Erk1/2 MAPK
were from New England Biolabs (Beverly, Mass.). A monoclonal antibody to
PTP1B (Ab-2) was obtained from Oncogene Research Products (San Diego,
Calif.). Tris-acryl protein G was from Pierce (Rockford, Ill.). Horseradish per-
oxidase-conjugated secondary anti-mouse and anti-rabbit immunoglobulin G
antibodies were obtained from Amersham Pharmacia Biotech (Piscataway, N.J.),
2-deoxy-D-[3H]glucose was purchased from ICN (Costa Mesa, Calif.). All other
chemicals and reagents, unless otherwise noted, were obtained from Sigma.
Cell culture. 3T3-L1 preadipocytes were cultured in Dulbecco’s modified Ea-
gle’s medium containing 25 mM glucose (DMEM) plus 10% fetal calf serum in
a 5% CO2 atmosphere and were differentiated to adipocytes as previously de-
scribed (35). Briefly, confluent cells were placed in differentiation medium
(DMEM containing 10% fetal bovine serum, 100 nM insulin, 0.25 M dexa-
methasone, and 500 M isobutylmethylxanthine) for 2 days. The medium was
then changed to DMEM containing 10% fetal bovine serum and 100 nM insulin.
After an additional 6 days of incubation, the cells were used in the indicated
experiments.
RT-PCR and Northern blot analysis for NAD(P)H catalytic subunit homologs.
Reverse transcription-PCR (RT-PCR) was performed as described by Cheng et
al. (8). For Northern analysis, total RNA was isolated from differentiated 3T3-L1
adipocytes using the TRIzol reagent (Invitrogen). Human HepG2 hepatoma
cells, human HL-60 promyelocytic leukemia cells, and murine MMC (SV40-
transformed glomerular mesangial cells) were used as positive controls for Nox1,
Nox2, and Nox4, respectively. RNA was separated electrophoretically on form-
aldehyde-agarose gels, transferred to Hybond-N membrane (Amersham Bio-
sciences), and hybridized with C-terminal cDNA probes of murine Nox1, Nox2,
and Nox4 according to the manufacturer’s recommendations (NorthernMax;
Ambion, Austin, Tex.). cDNA probes were synthesized using the RT-PCR
method (Invitrogen) and sequenced before probing to Hybond-N membranes
to confirm their sequence specificity. Primers used for cDNA probe synthesis
were Nox1 (forward, 5-AAG TGG CTG TAC TGG TTG GG-3; reverse,
5-CCA CAT AAG AAA ACC CCC ACC G-3; cDNA length, 411 bp), Nox2
(forward, 5-CCA GTG AAG ATG TGT TCA GCT A-3; reverse, 5-AGG
GTG TTC ACT TGC AAT GGT C-3; cDNA length, 406 bp), and Nox4
(forward, 5-GAA GCC CAT TTG AGG AGT CA-3; reverse, 5-GGG TCC
ACA GCA GAA AAC TC-3; cDNA length, 409 bp).
Generation of recombinant wild-type and Nox4 deletion constructs in adeno-
viral vectors. The human wild-type Nox4 cDNA was cloned as described previ-
ously (8). cDNA constructs for dominant-negative Nox4 lacking NAD(P)H or
FAD-NAD(P)H binding domains were generated by removing C-terminal se-
quences from the wild-type Nox4 cDNA encoding 578 amino acids (GenBank
accession number AF254621) for NAD(P)H (including start codon through
1,150 bp; amino acids 1 to 383) or for FAD-NAD(P)H (start codon through 938
bp; amino acids 1 to 312) (Fig. 1). These cDNA constructs were introduced into
defective Ad-5 adenoviruses using the Adeno-X expression system, which is
driven by the human cytomegalovirus immediate-early promoter-enhancer and
also contains a bovine growth hormone polyadenylation signal, according to the
instructions provided by the manufacturer (BD Biosciences). The presence of the
intact cDNA inserts was characterized in recombinant adenovirus DNA purified
from transfected 293 cells by PCR. Recombinant virus was recovered from a
large-scale preparation of adenovirus from 293 cells, and titers were determined
using the Adeno-X rapid titer kit (BD Biosciences). A recombinant adenovirus
encoding bacterial -galactosidase was used as control.
Adenoviral transduction of 3T3-L1 adipocytes. 3T3-L1 adipocytes were trans-
duced with recombinant adenovirus according to an established protocol (40).
Briefly, after differentiation in 3T3-L1 cells, the various recombinant adenovirus
constructs (600 infection-forming units/cell) were preincubated for 100 min at
room temperature in DMEM containing 0.5% bovine serum albumin (BSA) and
0.5 g of polylysine/ml. After preincubation, adenovirus infection of 3T3-L1
adipocytes was performed by overnight incubation in DMEM containing 0.5%
BSA. The next day, the medium was replaced with complete medium containing
10% fetal bovine serum and 100 nM insulin; 72 h posttransduction, the cells were
used for experiments after starving overnight with serum-free medium.
FIG. 1. Schematic structure of Nox4 wild-type and deletion con-
structs expressed in 3T3-L1 cells by adenoviral gene delivery. The
full-length wild-type Nox4 protein is shown with the major functional
domains indicated. The construct with the deleted NAD(P)H binding
domain is designated NADPH, and the construct with both cofactor
domains deleted is indicated as FAD/NADPH.
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Detection of the transduced Nox4 deletion constructs was performed by RT-
PCR, since the available antibody to Nox4 was directed at a C-terminal protein
epitope that is lacking in both of the recombinant constructs. Using reagents
provided by Ambion, oligo(dT)-directed RT of cellular RNA was followed by 35
cycles of PCR with a reverse primer (5-AATGATGGTGACTGGC-3) and a
forward primer (5-TCTCAGTGAATTACAGT-3) to generate a Nox4 frag-
ment of 550 bp.
Transfection of siRNAs into 3T3-L1 adipocytes. The following siRNAs were
designed to target the murine Nox4 cDNA sequences: siRNA 1 (5-AACGAA
GGGGTTAAACACCTC-3); siRNA 3 (5-AAAAGCAAGACTCTACACAT
C-3); scrambled, control siRNA (5-CAGTCGCGTTTGCGACTGG-3)
(Dharmacon, Inc.). Either 20 nmol of scrambled or siRNA 1 or 3, or 10 nmol
each of siRNA 1 and siRNA 3 was electroporated into differentiated 3T3-L1
adipocytes as described elsewhere (6). Briefly, cells were electroporated with
siRNA and reseeded in six-well plates; 48 h later, cells were starved for 4 h and
stimulated without or with insulin (100 nM) for 5 min prior to lysis with ice-cold
buffer containing 50 mM HEPES (pH 7.5), 150 mM NaCl, 1% Triton X-100, 100
mM sodium fluoride, 1 mM EGTA, 1 mM EDTA, 2 mM sodium vanadate, 10
mM sodium pyrophosphate, 1 mM phenylmethylsulfonyl fluoride, and a protease
inhibitor cocktail (Sigma). For immunoprecipitation of Nox4 protein, lysates
were briefly sonicated and cleared by centrifugation at 13,000  g for 10 min,
followed by immunoprecipitation using the polyclonal Nox4 antibody, sodium
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), transfer onto
polyvinylidene difluoride (PVDF) membranes, and Western blotting with Nox4-
specific antibody using standard methods.
The Nox4 antibody was generated from a His-tagged recombinant fragment of
human Nox4 encoding the C-terminal amino acids 320 to 428, which has 95%
homology with murine Nox4 in that region. After purification on a nickel-
nitrilotriacetic acid column (Qiagen), a polyclonal antibody was generated in
rabbits. The rabbit antiserum was purified on a protein A column and also passed
through a bacterial lysate column (Pierce) to remove nonspecific reactivity with
Escherichia coli antigens.
Assay of intracellular H2O2 in 3T3-L1 adipocytes. Intracellular generation of
H2O2 was visualized as described previously (2, 5, 35). After wild-type and
dominant-negative Nox4 encoding recombinant adenovirus transduction into
3T3-L1 adipocytes, cells were stimulated with insulin (100 nM) for 5 min. Fol-
lowing stimulation, 3T3-L1 adipocytes were washed with minimal essential me-
dium (lacking phenol red) and then incubated in the dark for 10 min with
CM-DCF-DA. The fluorescence of CM-DCF-DA was measured by using a
Bio-Rad confocal microscope at an excitation wavelength of 488 nm and emis-
sion at 515 to 540 nm. To avoid photooxidation of the indicator dye, the fluo-
rescence image was collected by a single rapid scan with identical parameters for
all samples. Where indicated, the fluorescence intensity was quantitated from
sampled images using Scion Image software (Scion Corporation, Frederick,
Md.).
Immunoblotting. After wild-type and dominant-negative Nox4-encoding or
wild-type and dominant-negative PTP1B-encoding recombinant adenovirus
transduction or siRNA transfection into 3T3-L1 adipocytes, cells were stimulated
with insulin for 5 min and then lysed in buffer containing 50 mM HEPES (pH
7.5), 150 mM NaCl, 1% Triton X-100, 100 mM sodium fluoride, 1 mM EGTA,
1 mM EDTA, 2 mM sodium vanadate, 10 mM sodium pyrophosphate, 1 mM
phenylmethylsulfonyl fluoride, and a protease inhibitor cocktail (Sigma). The
lysates were briefly sonicated and centrifuged at 13,000 g for 10 min, and 75 g
of protein of the cleared supernatant was resolved by SDS-PAGE and trans-
ferred to PVDF membrane using a semidry Western blotting apparatus (AP
Biotech). PVDF membranes were subjected to immunoblotting with either
monoclonal antibody for phosphotyrosine (4G10) to detect insulin receptor
-subunit and IRS tyrosine phosphorylation, polyclonal antibody to detect phos-
pho-Akt, and monoclonal antibody to detect phospho-Erk1/2 MAPK, or addi-
tional antibodies to detect total protein levels of the insulin receptor -subunit,
IRS-1, Akt, and ERK1/2 MAPK where indicated. Following incubation with
horseradish peroxidase-conjugated secondary antibodies, proteins were visual-
ized by ECL according to the instructions provided by the manufacturer. The
immunoblotting signals were quantitated using an ImageStation 440 (Kodak).
Protein was measured by the method of Bradford (7).
Immunoprecipitation of IRS-1 to assess p85 (PI 3-kinase subunit) binding.
Cell treatments and preparation of lysates from 3T3-L1 adipocytes were per-
formed as described above. Briefly, cells were serum starved overnight in DMEM
containing 0.5% BSA. After stimulation with insulin as indicated, cells were
snap-frozen with liquid nitrogen and lysed in ice-cold lysis buffer. The lysates
were briefly sonicated and centrifuged at 15,000  g for 10 min. After normal-
izing the protein concentration, cleared lysates were incubated with IRS-1 anti-
body overnight at 4°C. The samples were then incubated for 2 h with a 50%
(vol/vol) slurry of protein A-agarose at 4°C, pelleted by centrifugation in a
microcentrifuge, and washed three times with ice-cold lysis buffer. SDS gel
sample buffer was then added, and the samples were heated to boiling, processed
by SDS gel electrophoresis, and transferred to PVDF membranes. Membranes
were probed overnight with antibody to the p85 noncatalytic subunit of PI
3-kinase. Following incubation with horseradish peroxidase-conjugated second-
ary antibodies, bound antibody was detected using ECL. To reprobe the blot, the
membrane was incubated for 30 min at 50°C in stripping buffer (62.5 mM
Tris-HCl [pH 6.8], 100 mM 2-mercaptoethanol, and 2% SDS) and then washed
several times with TBST (20 mM Tris-HCl [pH 7.6], 137 mM NaCl, and 0.1%
Tween 20). The PVDF membrane was reprobed with the IRS-1 antibody, and
bound antibody was detected as described above.
Glucose uptake in 3T3-L1 adipocytes. Adenovirus-transduced or siRNA-trans-
fected 3T3-L1 adipocytes were starved for serum for 4 h, washed with KRPH
buffer (5 mM Na2HPO4, 20 mM HEPES [pH 7.4], 1 mM MgSO4, 1 mM CaCl2,
136 mM NaCl, 4.7 mM KCl, 0.2% [wt/vol] BSA), and treated with 100 nM insulin
in KRPH buffer where indicated. Following 11 min of incubation with insulin,
glucose uptake was assessed by the addition of 100 M 2-deoxy-D-glucose con-
taining 0.5 Ci of [3H]2-deoxy-D-glucose as described previously (14). The re-
action was stopped 4 min later by washing the cells three times with ice-cold
phosphate-buffered saline. The cells were then solubilized in 0.05% (wt/vol) SDS
at 37°C for 30 min, and aliquots were subjected to scintillation counting. Non-
specific uptake (10% of the total) was determined in the presence of cytocha-
lasin B (50 M) and was subtracted from the total uptake.
Specific activity of PTP1B. Under strictly anaerobic conditions to preserve the
endogenous level of catalytic activity and avoid air oxidation (47), PTP1B was
immunoprecipitated from lysates of transduced 3T3-L1 adipocytes (375 g of
protein) with a monoclonal antibody directed at a C-terminal epitope that pre-
serves its enzymatic activity (Ab-2) followed by adsorption to Tris-acryl protein
G. PTPase activity was measured by the hydrolysis of para-nitrophenyl phosphate
in the anaerobic chamber in washed immunoprecipitates as our investigators
have reported previously (35). The reaction was terminated by the addition of 50
l of 1 M NaOH, and the absorption was determined at 410 nm.
Statistical analyses. Quantitative data are presented as the mean  standard
error of the mean for three to five experiments. Statistical analysis was based on
Student’s t test for comparison of two groups and one-way analysis of variance for
multiple group comparisons. A P value less than 0.05 was used to determine
statistical significance.
RESULTS
Expression of Nox family homologs in insulin-sensitive
cells. Using RT-PCR techniques as reported previously (8), we
identified relatively high expression of Nox4 in human subcu-
taneous and omental adipose tissue, human HepG2 hepatoma
cells, and SV40-transformed human endothelial (HAD-
MEC-5) cells compared to other Nox family homologs, includ-
ing Nox1, Nox2, Nox3, Nox5, Duox1, and Duox2 (Fig. 2A). We
then confirmed the relatively high abundance of Nox4 mRNA
and undetectable mRNA expression for Nox1 and Nox2 in
differentiated 3T3-L1 adipocytes by RT-PCR and Northern
blot analysis, using positive control cell lines known to express
the candidate Nox homologs (Fig. 2B and C). The expression
of Nox2 in the adipose tissue samples shown in Fig. 2A is likely
due to the presence of this abundant leukocyte homolog
(gp91phox) in trapped blood cells that were captured in the
RNA sample.
Protein expression of Nox4 in 3T3-L1 cells was confirmed
using a specific antibody for Nox4 made to a recombinant
protein antigen encoding the C-terminal region of the protein
(Fig. 3A). These data raised the possibility that the NAD(P)H
oxidase homolog Nox4 might play a role in insulin-stimulated
oxidant production in adipose cells.
Expression of recombinant Nox4 constructs and PTP1B in
3T3-L1 adipocytes. In order to test this hypothesis more di-
rectly, we used adenovirus-mediated gene delivery to overex-
press recombinant Nox4 constructs including wild-type and
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two deletion mutants, one lacking the NAD(P)H binding do-
main and the other lacking both the FAD and NAD(P)H
binding domains, as well as a recombinant -galactosidase
construct as control. Seventy-two hours postinfection, no cyto-
toxicity was apparent in the cells transduced with any of the
constructs. Since the only available Nox4 antibody was directed
at the C-terminal heme binding domain of Nox4, we could not
perform Western blotting to characterize the level of expres-
sion of the recombinant constructs. However, expression of
mRNA for each of the transduced Nox4 constructs was de-
tected using RT-PCR (Fig. 3B). The predicted 550-bp cDNA
band revealed comparable expression of wild-type human
Nox4 as well as the two deletion constructs expressed in
3T3-L1 adipocytes. Since the PCR primers were homologous
FIG. 2. Expression of Nox family homologs in adipose tissue and various cultured cells. (A) RT-PCR of Nox family homologs. Total RNA was
prepared using the TRIzol reagent, and RT-PCR was performed with primers specific for human Nox1, Nox2, Nox3, Nox4, Nox5, Duox1, and
Duox2 in human subcutaneous and omental adipose tissue, HepG2 hepatoma cells, and SV40-transformed human microvascular endothelial
(HADMEC-5) cells using previously reported techniques (8). N1 to N5, Nox1 to Nox5; D1 and D2, Duox 1 and 2; G, glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) as an internal control; M, molecular size markers. (B) RT-PCR was performed using RNA isolated from differentiated
3T3-L1 adipocytes as described in Materials and Methods using primers for PCR analysis that were specific to murine Nox family homologs Nox1,
Nox2, and Nox4. Control cell lines included CMT-93 (murine colon carcinoma cells), HL-60 (human leukemia cells), and MMC (murine mesangial
cells). (C) Northern blot analysis of Nox4 mRNA expression in differentiated 3T3-L1 adipocytes. Total RNA was isolated from the indicated cells
using the TRIzol reagent, and Northern blot analysis using Nox1-, Nox2-, and Nox4-specific cDNA probes or GAPDH as a loading and transfer
control was performed as described in Materials and Methods.
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only to the transduced human Nox4 sequence, no cDNA band
was detected in the nontransduced or the -galactosidase-
transduced murine 3T3-L1 adipocytes.
For comparison with the studies on the effects of Nox4,
3T3-L1 adipocytes were also transduced with recombinant
wild-type human PTP1B and a site-directed catalytically inac-
tive mutant enzyme (Cys2153Ser) using the same adenovirus
system (12). By Western blot analysis, the level of PTP1B
protein in the transduced 3T3-L1 adipocytes was increased 10-
to 15-fold compared with cells transduced with the -galacto-
sidase-encoding adenovirus (Fig. 3C).
Effect of expression of recombinant Nox4 and PTP1B on the
insulin-induced oxidant signal. Insulin-stimulated generation
of cellular reactive oxygen species was measured in the trans-
duced 3T3-L1 adipocytes after loading with the sensitive fluo-
rescent oxidant indicator dye CM-DCF-DA (35). At 72 h pos-
tadenoviral infection, adipocytes were stimulated with 100 nM
insulin for 5 min, and in control cells a rapid increase in
intracellular DCF fluorescence was detected within 1 min using
confocal microscopy (Fig. 4). Compared to controls (either
uninfected or those infected with recombinant -galactosi-
dase), insulin-induced DCF fluorescence was increased by 21%
(P 	 0.02) in cells overexpressing wild-type Nox4. Importantly,
insulin-induced oxidant generation was sharply attenuated by
72 to 75% in cells transduced with either of the Nox4 deletion
constructs (P  0.001). These findings are consistent with the
deletion constructs acting in a dominant-negative fashion to
inhibit insulin-induced oxidant generation, and they provide
strong evidence that the NAD(P)H oxidase system in adipo-
cytes involves the catalytic activity of Nox4. In parallel, over-
expression of wild-type PTP1B, but not the catalytically inac-
tive mutant, suppressed insulin-stimulated oxidant generation
to a similar extent as the Nox4 deletion constructs, further
suggesting that the post-insulin receptor signal transduction
cascade is largely coupled to the generation of the oxidant
signal (Fig. 4).
Effects of expression of recombinant Nox4 and PTP1B con-
structs on insulin receptor and IRS tyrosine phosphorylation.
The effects of Nox4 or PTP1B on insulin-induced tyrosine
phosphorylation of the insulin receptor (Fig. 5A) and IRS-1/2
(Fig. 5B) were then assessed using Western blot analysis with
antiphosphotyrosine antibody. In untransduced cells, insulin
stimulation for 5 min increased insulin receptor tyrosyl phos-
phorylation by five- to sixfold and IRS-1/2 tyrosyl phosphory-
lation by three- to fourfold. Adenovirus-directed -galactosi-
dase expression had no effect on basal or insulin-stimulated
insulin receptor or IRS-1/2 tyrosyl phosphorylation. Overex-
pression of wild-type Nox4 or inactive PTP1B did not affect
basal or insulin-stimulated insulin receptor or IRS protein
tyrosine phosphorylation. In cells expressing either of the dom-
inant-negative Nox4 constructs, however, insulin-stimulated
phosphorylation was decreased by 46 to 56% for the insulin
receptor (P 	 0.001) and 28 to 58% for the IRS proteins (P 	
0.01) versus control cells transduced with -galactosidase. For
comparison, wild-type PTP1B transduction sharply reduced
the insulin-stimulated tyrosine phosphorylation of the insulin
receptor- subunit and IRS-1/2 proteins by 65% (P  0.001)
and 73% (P  0.001), respectively.
Effect of siRNA-induced reduction of Nox4 protein mass on
insulin-stimulated insulin receptor tyrosine phosphorylation.
FIG. 3. Expression of Nox4 protein in 3T3-L1 adipocytes after
transfection of siRNA oligonucleotides and expression of recombinant
Nox4 mRNA and PTP1B protein in 3T3-L1 adipocytes following ad-
enovirus-mediated gene delivery. (A) 3T3-L1 adipocytes were trans-
fected with Nox4-specific (siRNA 1, 3, or both together) or a scram-
bled control siRNA oligonucleotide and reseeded in six-well plates (6).
After 48 h of incubation, cell lysates were prepared and incubated with
Nox4 polyclonal antibody to immunoprecipitate Nox4 protein. Immu-
noprecipitates were separated by SDS-PAGE and reblotted with Nox4
antibody as described in Materials and Methods. A representative blot
demonstrating expression of Nox4 protein at 
65 kDa and a reduction
in Nox4 abundance following loading of specific siRNA oligonucleo-
tides is shown. Protein expression for the insulin receptor -subunit is
shown as an experimental control. The bar graph shows mean data
from replicate immunoblots quantitated using ImageStation 440
(Kodak). *, P 	 0.05; **, P 	 0.01 versus control cells transfected with
the scrambled siRNA. (B) At 72 h following transduction of differen-
tiated 3T3-L1 adipocytes with adenovirus encoding -galactosidase or
the indicated Nox4 constructs, total RNA was prepared using the
TRIzol reagent and RT-PCR was performed with Nox4-specific prim-
ers as described in Materials and Methods. Nox4 was detected as a

550-bp band in the ethidium bromide-stained agarose gel. (C) Cell
lysates were prepared from 3T3-L1 cells 72 h after transduction with
control adenovirus encoding -galactosidase, wild-type PTP1B, or a
site-directed catalytically inactive (Cys2153Ser) PTP1B construct
(mPTP1B). Proteins were separated by SDS-PAGE and immunoblot-
ted with PTP1B antibody as described in Materials and Methods. The
50-kDa PTP1B protein band is indicated. Protein expression for the
insulin receptor -subunit is shown as an experimental control.
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To provide confirmatory evidence into the potential role of
Nox4 in the insulin signaling pathway, we also performed ex-
periments in which Nox4 protein abundance was reduced by
loading 3T3-L1 adipocytes with siRNA constructs directed at
murine Nox4. Forty-eight hours after transfection, immuno-
precipitation of Nox4 and Western blotting demonstrated that
loading with siRNA 1 or siRNA 3 resulted in a 32 and 30% (P
	 0.05) decrease in Nox4 protein mass, respectively, while cells
transfected with a mixture of both siRNAs had a decrease in
Nox4 protein to 50% (P 	 0.01) of the control level in cells
transfected with a scrambled, control siRNA preparation (Fig.
3A). There was no change in the mass of the insulin receptor
-subunit, which was used as an internal control.
Following stimulation with insulin, the siRNA-transfected
cells with reduced endogenous Nox4 expression demonstrated
a 49 to 64% (P 	 0.01) decrease in insulin receptor tyrosyl
phosphorylation compared to the control cells transfected with
the scrambled siRNA controls (Fig. 5D). Thus, cellular reduc-
tion of Nox4 protein abundance significantly affected the ini-
tiation of the insulin signaling cascade to a similar degree as
the dominant-negative effects of the transduced Nox4 deletion
constructs (Fig. 5A).
Effect of expression of recombinant Nox4 constructs and
wild-type PTP1B on PI 3-kinase p85 subunit binding to IRS-1.
We next assessed whether the effects of Nox4 affected down-
stream insulin signaling to the PI3-kinase pathway in the
3T3-L1 cells (Fig. 6). Overexpression of wild-type Nox4 itself
did not significantly affect the insulin-stimulated association
between the p85 subunit of PI 3-kinase and IRS-1. However,
in cells overexpressing the Nox4 FAD-NAD(P)H deletion con-
struct or wild-type PTP1B, the stimulation of the p85 subunit
association with IRS-1 was reduced by 30 to 33% compared to
control (P  0.001).
Effect of transfection of Nox4 siRNA on insulin-stimulated
Akt phosphorylation. To evaluate whether a reduction in Nox4
mass affected insulin signaling to downstream kinases, 48 h
after loading with Nox4 siRNA, cells were starved for 4 h in
DMEM with 0.5% BSA and then treated with 100 nM insulin
for 5 min. Immunoblotting of cell lysates with phospho-Akt-
specific polyclonal antibody revealed that insulin stimulated a
six- to sevenfold increase in Akt phosphorylation in control
cells transfected with the scrambled siRNA. In cells trans-
fected with the Nox4-specific siRNA, however, insulin-stimu-
lated Akt phosphorylation was decreased by 35 to 48% (P 	
0.007) compared to the control response (Fig. 7).
Effect of expression of recombinant Nox4 and PTP1B con-
structs on Erk1 and Erk2 MAPK activation. Compared to cells
transduced with the control adenovirus, insulin-stimulated
phosphorylation of both Erk1 and Erk2 was decreased by 41 to
59% (P	 0.02) in cells expressing the Nox4 deletion constructs
and decreased by 38% (P 	 0.002) in the cells overexpressing
wild-type PTP1B (Fig. 8). Overexpression of wild-type Nox4 or
the inactive PTP1B had no effect on insulin-stimulated Erk
phosphorylation, and the amount of Erk protein was not al-
tered by the cell transductions.
Effect of expression of Nox4 cDNA constructs and siRNA on
insulin-stimulated glucose uptake. In cells transduced with the
control adenovirus, the basal glucose uptake in 3T3-L1 adipo-
cytes was increased by 30% and was increased 
2-fold with
each of the recombinant Nox4 deletion constructs (Fig. 9A).
Following insulin stimulation, glucose uptake was increased by
3.9- and 3.0-fold over the basal level in the control, untrans-
duced cells and in the -galactosidase-transduced controls,
respectively. In the wild-type Nox4-overexpressing cells, the
level of insulin-stimulated glucose uptake was increased by
22% over the level in control cells (P 	 0.05), but due to the
increase in basal uptake the degree of stimulation was reduced
to 2.4-fold. In 3T3-L1 adipocytes overexpressing the dominant-
negative Nox4 FAD-NAD(P)H construct, the level of insu-
lin-stimulated glucose transport was decreased by 32% com-
pared to the wild-type overexpressing cells (P	 0.001), and the
level of insulin stimulation was markedly reduced to only 1.7-
fold compared to controls. Changes in insulin-stimulated glu-
cose uptake with the Nox4 NAD(P)H construct were at an
intermediate level.
3T3-L1 adipocytes electroporated with the control, scram-
bled siRNA construct showed relatively high basal glucose
transport that was increased by 37% with insulin stimulation
(Fig. 9B). Cells transfected with the active Nox4 siRNAs ex-
hibited a 30 to 44% reduction in basal glucose transport and a
similar drop in the level of insulin-stimulated glucose uptake.
Taken together with the Nox4 transduction studies noted
above, these results suggest that Nox4 overexpression helps
potentiate, and a reduction in Nox4 mass reduces, the level of
insulin-stimulated glucose transport in 3T3-L1 adipocytes.
Role of Nox4 in the modulation of insulin receptor tyrosine
phosphorylation by PTP1B. In order to determine if Nox4
interacted with PTP1B in its effect on insulin signal transduc-
tion, we cotransduced two recombinant adenoviruses to in-
crease the level of expression of PTP1B and wild-type Nox4 or
the dominant-negative FAD-NAD(P)H construct (Fig. 5C).
As described above and shown in Fig. 5A, overexpression of
PTP1B alone reduced the insulin-stimulated autophosphory-
FIG. 4. Effect of adenoviral expression of recombinant Nox4 and
PTP1B constructs on insulin-stimulated production of H2O2 in 3T3-L1
adipocytes. Seventy-two hours after transduction with the indicated
adenovirus constructs, differentiated 3T3-L1 adipocytes were starved
overnight in serum-free medium, loaded with CM-DCF-DA, and stim-
ulated with 100 nM insulin for 5 min as described in Materials and
Methods. Intracellular H2O2 production was detected by fluorescence
of DCF in situ using confocal microscopy as reported previously (35).
*, P 	 0.02; ***, P  0.001 versus control.
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FIG. 5. Effect of adenoviral expression of recombinant Nox4 and PTP1B constructs on insulin-stimulated tyrosine phosphorylation of the
insulin receptor -subunit and IRS proteins. (A) Representative antiphosphotyrosine (4G10) and anti-insulin receptor -subunit immunoblots of
3T3-L1 cell lysates transduced with adenovirus encoding wild-type Nox4 as well as two dominant-negative constructs lacking binding domains for
NAD(P)H or FAD/NAD(P)H or wild-type PTP1B and mutant PTP1B, following stimulation of serum-starved cells with 100 nM insulin for 5 min.
The migration positions of the tyrosine-phosphorylated insulin receptor -subunit (95 kDa) are indicated as pY-IR-. Mean data for the
phosphotyrosine density of the insulin receptor -subunit from replicate immunoblots quantitated using an ImageStation 440 (Kodak) are shown
in the bar graph. ***, P  0.001 versus control -galactosidase-encoding adenovirus-transduced 3T3-L1 adipocytes. (B) Samples identical to those
described in the legend for panel A were analyzed for phosphotyrosine content of IRS1/2 and IRS1 protein using antiphosphotyrosine antibodies
(4G10) and IRS-1 antibody following stimulation of serum-starved cells with 100 nM insulin for 5 min. The migration positions of the
tyrosine-phosphorylated IRS1/2 (
 185 kDa) are indicated as pY IRS-1/2. Mean data for the phosphotyrosine density of IRS-1/2 from replicate
immunoblots are shown in the bar graph. **, P	 0.01; ***, P 0.001 versus control cells transduced with the -galactosidase-encoding adenovirus.
(C) Representative antiphosphotyrosine (4G10) and anti-insulin receptor -subunit immunoblots of 3T3-L1 cell lysates transduced with adenovirus
encoding wild-type PTP1B or mutant PTP1B and cotransduced with adenovirus encoding Nox4 or the FAD/NAD(P)H Nox4 deletion construct
where indicated, following stimulation of serum-starved cells with 100 nM insulin for 5 min. Mean data for the phosphotyrosine density of the
insulin receptor -subunit from replicate immunoblots are shown in the bar graph. **, P 	 0.01; ***, P  0.001 versus control cells transduced
with the -galactosidase-encoding adenovirus. (D) Effect of reduction of Nox4 mass on insulin-stimulated tyrosine phosphorylation of the insulin
receptor -subunit, as shown in representative antiphosphotyrosine (4G10) and anti-insulin receptor -subunit (IR-) immunoblots of 3T3-L1 cell
lysates transfected with control (scrambled) or Nox4-specific siRNA oligonucleotides. Following stimulation of serum-starved cells with 100 nM
insulin for 5 min, cell lysates were prepared and SDS-PAGE and immunoblotting were performed. Mean data for the phosphotyrosine density of
the insulin receptor -subunit from replicate immunoblots are shown in the bar graph. *, P 	 0.05; **, P 	 0.01 versus control transfected 3T3-L1
adipocytes.
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lation of the insulin receptor by 67%. Cooverexpression of
Nox4 along with PTP1B significantly diminished the effect of
PTP1B alone on insulin receptor -subunit tyrosine phosphor-
ylation by 46%. When cooverexpressed, the FAD-NAD(P)H
construct had no significant effect on the reduction of insulin-
stimulated receptor tyrosine phosphorylation by PTP1B over-
expression (Fig. 5C).
In control experiments, neither overexpression of catalyti-
cally inactive PTP1B (mPTP1B) alone nor cotransduction of
Nox4 along with mPTP1B affected insulin receptor autophos-
phorylation (Fig. 5C), as observed in our studies described
above (Fig. 5A). In addition, cotransduction the FAD-
NAD(P)H deletion construct along with mPTP1B inhibited
insulin receptor tyrosine phosphorylation by 40%, suggesting
that the underlying interaction between the dominant-negative
Nox4 homolog and the endogenous active PTP1B was re-
tained, similar to the experiments shown in Fig. 5A.
Role of Nox4 in the modulation of PTP1B catalytic activity.
To determine whether Nox4 overexpression affected the activ-
ity of PTP1B, we transduced 3T3-L1 cells with active PTP1B
with and without cotransduction with active Nox4 and mea-
sured PTP1B activity specifically in immunoprecipitates using
anaerobic conditions to avoid artifactual enzyme oxidation and
inhibition by air exposure (Fig. 10). As our investigators re-
ported previously (35), insulin stimulation inhibited the endog-
enous activity of PTP1B in 3T3-L1 cells by 
50%, and viral
infection with the recombinant virus encoding -galactosidase
had no nonspecific effects in control studies. In the absence of
insulin stimulation, transduction of recombinant human
PTP1B increased the activity in the immunoprecipitates by
52%, which was reduced by 53% in the cells that were cotrans-
duced with the Nox4 enzyme. In the cells overexpressing
PTP1B without or with cotransduction of Nox4, insulin stim-
ulation reduced PTPase activity in the PTP1B immunoprecipi-
tates by 16 and 23%, respectively. These findings reveal a clear
association between the activity of PTP1B as isolated from the
intact cells and the activity of Nox4.
DISCUSSION
Many years prior to the identification of the insulin receptor
and the elucidation of its molecular mechanism of signal trans-
duction involving receptor and substrate protein tyrosine phos-
phorylation, researchers had recognized that small oxidant
molecules and reagents that generated H2O2 in the cell culture
medium could mimic insulin action on glucose transport in
adipose cells (10, 33). The early studies of oxidants in insulin
signaling also demonstrated that H2O2 was actually elaborated
during treatment of cells with physiological levels of insulin,
raising the possibility that cellular H2O2 generation was cou-
pled to insulin stimulation (11, 36). Studies from different
laboratories have since shown similar effects of other hor-
mones, growth factors, and cytokines on the generation of
FIG. 6. Effect of adenoviral expression of Nox4 deletion constructs
and wild-type PTP1B on the association of the p85 subunit of PI
3-kinase with IRS-1. Transduction of 3T3-L1 adipocytes with adeno-
virus, stimulation of cells with insulin, and preparation of lysates were
performed as described in the legend to Fig. 4. After immunoprecipi-
tation of IRS-1 from the lysates as described in Materials and Meth-
ods, samples were separated by gel electrophoresis, transferred to
PVDF membranes, and probed overnight with antibody to the p85
noncatalytic subunit of PI 3-kinase. After stripping, PVDF mem-
branes were reprobed with the IRS-1 antibody for normalization. The
upper panel shows a representative immunoblot, and the bar graph in
the lower panel represents the p85 subunit binding to IRS-1 protein
from replicate immunoblots after quantitation. **, P  0.01; ***, P 
0.001 versus control -galactosidase-encoding adenovirus-transduced
3T3-L1 adipocytes.
FIG. 7. Effect of siRNA-induced reduction of Nox4 protein mass
on insulin-stimulated Akt phosphorylation in 3T3-L1 adipocytes. Re-
sults shown are representative anti-phospho-Akt and anti-Akt protein
immunoblots of 3T3-L1 cell lysates from cells transfected with control
(scrambled) or Nox4-specific siRNA oligonucleotides and following
stimulation of serum-starved cells with 100 nM insulin for 5 min as
described in Materials and Methods. The bar graph represents mean
data from replicate immunoblots after quantitation of signal density. *,
P	 0.05; **, P	 0.01; ***, P	 0.007 versus control 3T3-L1 adipocytes
transfected with the scrambled siRNA.
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reactive oxygen species and their potential involvement in sig-
naling pathways in a variety of effector cell types (3, 15, 20, 21).
In their initial biochemical characterization of this process,
Mukherjee and Lynn provided evidence that adipocyte plasma
membranes contained an NAD(P)H oxidase activity that was
activated by insulin (38). Later, Krieger-Brauer and colleagues
further demonstrated that within minutes, physiological con-
centrations of insulin stimulated H2O2 production by isolated
human fat cells due to a plasma membrane-bound Mn2-
dependent NAD(P)H oxidase enzyme (26, 28) that was also
present in 3T3-L1 adipocytes (27).
In the present work, we have initiated a molecular approach
to the identification of the insulin-stimulated cellular
NAD(P)H oxidase activity expressed in the insulin-sensitive
3T3-L1 adipocyte model system. The identification of a small
subfamily consisting of five mammalian NAD(P)H oxidase cat-
alytic subunits (Nox1 to Nox5) homologous to the catalytic
subunit of the respiratory burst oxidase, an NAD(P)H-depen-
dent, superoxide-generating enzyme present in phagocytes
known as gp91phox or Nox2 has facilitated our testing of the
potential involvement of individual candidate enzymes as ef-
fectors of the insulin-stimulated cellular production of H2O2
(8). Each of the Nox family gp91phox homologs encodes a
protein of 
65 kDa and contains five to six conserved pre-
dicted transmembrane -helices containing putative heme
binding regions and a flavoprotein homology domain contain-
ing predicted binding sites for both FAD and NAD(P)H. The
Nox homologs exhibit unique patterns of cellular expression:
Nox1 is predominantly expressed in colon and vascular smooth
muscle cells; Nox3 is expressed primarily in fetal tissues; Nox4
is expressed in kidney, placenta, and glioblastoma cells; and
Nox5 is expressed in spleen and uterus (8). Since we found that
Nox4 mRNA expression was relatively abundant in adipose
tissue, 3T3-L1 adipocytes, and HepG2 hepatoma cells (unpub-
lished data), in the present work we evaluated whether Nox4
played a role in cellular insulin-induced oxidant production
and insulin signaling. Indeed, using Nox4 deletion constructs
FIG. 8. Effect of adenoviral expression of recombinant Nox4 and
PTP1B constructs on Erk1 and Erk2 MAPK activation in 3T3-L1
adipocytes. Representative anti-phospho-MAPK and anti-MAPK pro-
tein immunoblots of lysates from 3T3-L1 cells transduced with the
indicated adenoviral constructs are shown. Following stimulation of
serum-starved cells with 100 nM insulin for 5 min, cell lysates were
prepared and immunoblotting was performed with a monoclonal an-
tibody to detect phospho-MAPK (ERK1/2) or anti-MAPK protein
antibody. (Upper panel) Representative immunoblots demonstrating
the phosphorylation state of MAPK and the MAPK protein level.
(Lower panel) Mean data from replicate immunoblots as shown in the
upper panel after quantitation of signal density. *, P 	 0.05 versus
control -galactosidase-encoding adenovirus-transduced 3T3-L1 adi-
pocytes.
FIG. 9. Effect of adenoviral expression of recombinant Nox4 or
PTP1B or siRNA-induced reduction in Nox4 protein mass on insulin-
stimulated glucose uptake in 3T3-L1 adipocytes. (A) After differenti-
ation, 3T3-L1 adipocytes were transduced with adenovirus encoding
-galactosidase as a control, wild-type Nox4, or constructs lacking
binding domains for NAD(P)H or FAD/NAD(P)H as shown and se-
rum starved for 2 h prior to stimulation with 100 nM insulin and
measurement of glucose transport by the uptake of 2-deoxy-D-glucose
as described in Materials and Methods. (B) Glucose transport mea-
sured in differentiated 3T3-L1 cells after transfection with control
(scrambled) or Nox4-specific siRNA oligonucleotides as shown. *, P 
0.05; **, P  0.01; ***, P  0.001 versus control cells stimulated with
insulin.
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that function in a dominant-negative fashion as well as confir-
matory studies using siRNA loading to reduce Nox4 abun-
dance, our data indicate clearly that Nox4 is involved in the
generation of H2O2 by insulin stimulation of differentiated
3T3-L1 adipocytes.
In addition to effects on insulin-stimulated H2O2 generation,
manipulation of Nox4 impacts significantly on both early and
late events in insulin signal transduction, including insulin-
stimulated insulin receptor and IRS-1 tyrosine phosphoryla-
tion, and the activation of downstream serine kinases and glu-
cose uptake. Thus, the effects of Nox4 on insulin signaling are
likely to be mediated by its effects on cellular oxidant genera-
tion, which our investigators have previously shown to modu-
late autophosphorylation of the insulin receptor and its major
postreceptor substrates upstream as well as downstream sig-
naling through the activation of cellular glucose transport (34,
35). Furthermore, we and others have shown that an endoge-
nous oxidant signal is integral to the cellular activation of Akt
via the upstream stimulation of PI 3-kinase (34, 43), which we
have demonstrated in the present work is also attenuated by
interference with Nox4 abundance or function.
The Nox4 deletion constructs lacking NAD(P)H or FAD/
NAD(P)H cofactor binding domains appear to act in a domi-
nant-negative fashion, inhibiting the generation of cellular
H2O2 and insulin signaling, perhaps by interfering with cou-
pling of the insulin receptor signal to endogenous Nox4. Be-
sides the identification of a role for Nox4 as a component of
the oxidant-generating system in 3T3-L1 cells reported here,
little is known about additional components of this signaling
complex that may have a regulatory role in insulin-sensitive cell
types. The well-characterized NAD(P)H oxidase complex from
phagocytic cells has a multisubunit structure, including plasma
membrane and cytosolic components whose complex forma-
tion is highly regulated and tightly coupled to enzymatic su-
peroxide production (1). Thus, overexpression of Nox4 with
the deleted cofactor domains may inhibit the formation of a
functional NAD(P)H oxidase complex in the 3T3-L1 system. A
more detailed characterization of additional components of
adipocyte Nox interaction proteins will help elucidate these
regulatory mechanisms. Several groups have recently reported
the cloning of Nox-interacting subunit proteins in nonphago-
cytic cells that have dramatic effects on the regulation of su-
peroxide production by Nox1 (e.g., reference 4). These, or
related proteins, may have a role in the regulation of Nox4
function in insulin and growth factor signaling. Also, small
GTPases or heterotrimeric G-proteins may be involved in cel-
lular oxidant production: rac has been shown to be a regulatory
component of the phagocytic NAD(P)H oxidase complex (1),
and evidence for the involvement of Gi2 in the adipocyte
oxidant-generating system responsive to insulin has been re-
ported (29).
Several cellular targets of H2O2 produced by growth factor
stimulation have been identified, and our understanding of
their role in signal transduction is beginning to unfold (24, 46).
One of the major effects of oxidants that mimic insulin action
involves the inhibition of thiol-dependent cellular enzymes,
including PTPases, that modulate various steps in signal trans-
duction from the insulin receptor (34, 35) as well as several
other growth factor receptor-induced tyrosine phosphorylation
cascades (31, 37). PTP1B is an intracellular PTPase that has
been implicated in the regulation of insulin signaling in cellular
and transgenic mouse studies (reviewed in references 18 and
44). Consistent with these reports, we found that PTP1B over-
expression consistently reduces insulin-stimulated tyrosine
phosphorylation of its receptor and IRS-1 (Fig. 5A to C). In
addition, the effect of PTP1B on insulin signal transduction as
well as the catalytic activity of PTP1B itself as isolated from the
3T3-L1 adipocytes following adenovirus-mediated gene deliv-
ery was markedly diminished by overexpression of Nox4 (Fig.
5C and 9). These results provide an important mechanistic link
between the insulin-stimulated oxidant-generating machinery
and PTP1B as a target of oxidative inhibition. Additional sig-
naling molecules that are potential targets of oxidative inhibi-
tion via the Nox4 pathway are other key mediators of growth
factor signaling, including, for example, the tyrosine phospha-
tase TCPTP (17) and the 3-PI(3,4,5)-PO4 phosphatase PTEN
(32).
Further work will be needed to identify additional proteins
that may have a role in the Nox4 signaling complex and to
define the mechanism of coupling oxidant generation via Nox4
to the insulin receptor signaling cascade. This active area of
research holds promise to define on a molecular basis a novel
regulatory system for insulin action that was initially identified
by observations made more than 30 years ago.
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FIG. 10. Effect of adenoviral expression of recombinant PTP1B
without or with Nox4 on the endogenous catalytic activity of PTP1B in
3T3-L1 adipocytes. Differentiated 3T3-L1 adipocytes were transduced
with adenovirus encoding -galactosidase as a control or wild-type
PTP1B without or with cotransduction of recombinant active Nox4 as
shown. Cells were serum starved for 2 h prior to stimulation with 100
nM insulin for 5 min. Cell lysates were immunoprecipitated with a
specific antibody for PTP1B, and PTPase activity of the adsorbed
enzyme was measured under an insert atmosphere by hydrolysis of
para-nitrophenyl phosphate as described in Materials and Methods.
***, P  0.001 versus the respective control samples without or with
insulin.
VOL. 24, 2004 Nox4 AND INSULIN SIGNALING IN 3T3-L1 ADIPOCYTES 1853
 at Thom
as Jefferson Univ on Decem
ber 5, 2007 
m
cb.asm
.org
D
ow
nloaded from
 
This work was supported by National Institutes of Health grant RO1
DK-43396 and a mentor-based postdoctoral fellowship grant from the
American Diabetes Association to B. J. Goldstein. K. Mahadev is
supported by a postdoctoral fellowship training grant award from the
National Institute of Diabetes and Digestive and Kidney Diseases.
REFERENCES
1. Babior, B. M., J. D. Lambeth, and W. Nauseef. 2002. The neutrophil
NADPH oxidase. Arch. Biochem. Biophys. 397:342–344.
2. Bae, Y. S., S. W. Kang, M. S. Seo, I. C. Baines, E. Tekle, P. B. Chock, and
S. G. Rhee. 1997. Epidermal growth factor (EGF)-induced generation of
hydrogen peroxide. Role in EGF receptor-mediated tyrosine phosphoryla-
tion. J. Biol. Chem. 272:217–221.
3. Bae, Y. S., J. Y. Sung, O. S. Kim, Y. J. Kim, K. C. Hur, A. Kazlauskas, and
S. G. Rhee. 2000. Platelet-derived growth factor-induced H2O2 production
requires the activation of phosphatidylinositol 3-kinase. J. Biol. Chem. 275:
10527–10531.
4. Banfi, B., R. A. Clark, K. Steger, and K. H. Krause. 2003. Two novel proteins
activate superoxide generation by the NADPH oxidase NOX1. J. Biol.
Chem. 278:3510–3513.
5. Barrett, W. C., J. P. DeGnore, Y. F. Keng, Z. Y. Zhang, M. B. Yim, and P. B.
Chock. 1999. Roles of superoxide radical anion in signal transduction me-
diated by reversible regulation of protein-tyrosine phosphatase 1B. J. Biol.
Chem. 274:34543–34546.
6. Bose, A., A. Guilherme, S. I. Robida, S. M. Nicoloro, Q. L. Zhou, Z. Y. Jiang,
D. P. Pomerleau, and M. P. Czech. 2002. Glucose transporter recycling in
response to insulin is facilitated by myosin Myo1c. Nature 420:821–824.
7. Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of
microgram quantities of protein utilizing the principle of protein-dye bind-
ing. Anal. Biochem. 72:248–254.
8. Cheng, G., Z. Cao, X. Xu, E. G. Van Meir, and J. D. Lambeth. 2001.
Homologs of gp91phox: cloning and tissue expression of Nox3, Nox4, and
Nox5. Gene 269:131–140.
9. Cross, A. R., J. Rae, and J. T. Curnutte. 1995. Cytochrome b-245 of the
neutrophil superoxide-generating system contains two nonidentical hemes.
Potentiometric studies of a mutant form of gp91phox. J. Biol. Chem. 270:
17075–17077.
10. Czech, M. P., J. C. Lawrence, Jr., and W. S. Lynn. 1974. Evidence for
electron transfer reactions involved in the Cu2- dependent thiol activation
of fat cell glucose utilization. J Biol. Chem. 249:1001–1006.
11. Czech, M. P., J. C. Lawrence, Jr., and W. S. Lynn. 1974. Evidence for the
involvement of sulfhydryl oxidation in the regulation of fat cell hexose
transport by insulin. Proc. Natl. Acad. Sci. USA 71:4173–4177.
12. Dadke, S., and J. Chernoff. 2002. Interaction of protein tyrosine phosphatase
(PTP) 1B with its substrates is influenced by two distinct binding domains.
Biochem. J. 364:377–383.
13. Elchebly, M., P. Payette, E. Michaliszyn, W. Cromlish, S. Collins, A. L. Loy,
D. Normandin, A. Cheng, J. Himms-Hagen, C. C. Chan, C. Ramachandran,
M. J. Gresser, M. L. Tremblay, and B. P. Kennedy. 1999. Increased insulin
sensitivity and obesity resistance in mice lacking the protein tyrosine phos-
phatase-1B gene. Science 283:1544–1548.
14. Fingar, D. C., S. F. Hausdorff, J. Blenis, and M. J. Birnbaum. 1993. Disso-
ciation of pp70 ribosomal protein S6 kinase from insulin- stimulated glucose
transport in 3T3-L1 adipocytes. J. Biol. Chem. 268:3005–3008.
15. Finkel, T. 2000. Redox-dependent signal transduction. FEBS Lett. 476:52–
54.
16. Flynn, J. T., M. Westbrooks, and K. A. Lucas. 1997. Establishment and
characterization of a line of adipose-derived human microvascular endothe-
lial cells (HADMEC-5) transformed by simian virus 40 large T antigen
expression: application to endotoxin research. Shock 8:45–54.
17. Galic, S., M. Klingler-Hoffmann, M. T. Fodero-Tavoletti, M. A. Puryer, T. C.
Meng, N. K. Tonks, and T. Tiganis. 2003. Regulation of insulin receptor
signaling by the protein tyrosine phosphatase TCPTP. Mol. Cell. Biol. 23:
2096–2108.
18. Goldstein, B. J. 2001. Protein-tyrosine phosphatase 1B (PTP1B): a novel
therapeutic target for type 2 diabetes mellitus, obesity and related states of
insulin resistance. Curr. Drug Targets Immune Endocr. Metabol. Disorders
1:265–275.
19. Goldstein, B. J. 2002. Protein-tyrosine phosphatases: emerging targets for
therapeutic intervention in type 2 diabetes and related states of insulin
resistance. J. Clin. Endocrinol. Metab. 87:2474–2480.
20. Griendling, K. K., and M. Ushio-Fukai. 2000. Reactive oxygen species as
mediators of angiotensin II signaling. Regul. Peptides 91:21–27.
21. Herrlich, P., and F. D. Bohmer. 2000. Redox regulation of signal transduc-
tion in mammalian cells. Biochem. Pharmacol. 59:35–41.
22. Junn, E., K. N. Lee, H. R. Ju, S. H. Han, J. Y. Im, H. S. Kang, T. H. Lee, Y. S.
Bae, K. S. Ha, Z. W. Lee, S. G. Rhee, and I. Choi. 2000. Requirement of
hydrogen peroxide generation in TGF-beta 1 signal transduction in human
lung fibroblast cells: involvement of hydrogen peroxide and Ca2 in TGF-
beta 1-induced IL-6 expression. J. Immunol. 165:2190–2197.
23. Kido, Y., J. Nakae, and D. Accili. 2001. The insulin receptor and its cellular
targets. J. Clin. Endocrinol. Metab. 86:972–979.
24. Kim, J. R., H. W. Yoon, K. S. Kwon, S. R. Lee, and S. G. Rhee. 2000.
Identification of proteins containing cysteine residues that are sensitive to
oxidation by hydrogen peroxide at neutral pH. Anal. Biochem. 283:214–221.
25. Klaman, L. D., O. Boss, O. D. Peroni, J. K. Kim, J. L. Martino, J. M.
Zabolotny, N. Moghal, M. Lubkin, Y. B. Kim, A. H. Sharpe, A. Stricker-
Krongrad, G. I. Shulman, B. G. Neel, and B. B. Kahn. 2000. Increased
energy expenditure, decreased adiposity, and tissue-specific insulin sensitiv-
ity in protein-tyrosine phosphatase 1B-deficient mice. Mol. Cell. Biol. 20:
5479–5489.
26. Krieger-Brauer, H. I., and H. Kather. 1992. Human fat cells possess a plasma
membrane-bound H2O2-generating system that is activated by insulin via a
mechanism bypassing the receptor kinase. J. Clin. Investig. 89:1006–1013.
27. Krieger-Brauer, H. I., and H. Kather. 1995. Antagonistic effects of different
members of the fibroblast and platelet-derived growth factor families on
adipose conversion and NADPH-dependent H2O2 generation in 3T3-L1
cells. Biochem. J. 307:549–556.
28. Krieger-Brauer, H. I., and H. Kather. 1995. The stimulus-sensitive H2O2-
generating system present in human fat-cell plasma membranes is multire-
ceptor-linked and under antagonistic control by hormones and cytokines.
Biochem. J. 307:543–548.
29. Krieger-Brauer, H. I., P. K. Medda, and H. Kather. 1997. Insulin-induced
activation of NADPH-dependent H2O2 generation in human adipocyte
plasma membranes is mediated by Gi2. J. Biol. Chem. 272:10135–10143.
30. Lambeth, J. D. 2002. Nox/Duox family of nicotinamide adenine dinucleotide
(phosphate) oxidases. Curr. Opin. Hematol. 9:11–17.
31. Lee, S. R., K. S. Kwon, S. R. Kim, and S. G. Rhee. 1998. Reversible inacti-
vation of protein-tyrosine phosphatase 1b in A431 cells stimulated with
epidermal growth factor. J. Biol. Chem. 273:15366–15372.
32. Lee, S. R., K. S. Yang, J. Kwon, C. Lee, W. Jeong, and S. G. Rhee. 2002.
Reversible inactivation of the tumor suppressor PTEN by H2O2. J. Biol.
Chem. 277:20336–20342.
33. Livingston, J. N., P. A. Gurny, and D. H. Lockwood. 1977. Insulin-like effects
of polyamines in fat cells. Mediation by H2O2 formation. J. Biol. Chem.
252:560–562.
34. Mahadev, K., X. Wu, A. Zilbering, L. Zhu, J. T. R. Lawrence, and B. J.
Goldstein. 2001. Hydrogen peroxide generated during cellular insulin stim-
ulation is integral to activation of the distal insulin signaling cascade in
3T3-L1 adipocytes. J. Biol. Chem. 276:48662–48669.
35. Mahadev, K., A. Zilbering, L. Zhu, and B. J. Goldstein. 2001. Insulin-
stimulated hydrogen peroxide reversibly inhibits protein-tyrosine phospha-
tase 1B in vivo and enhances the early insulin action cascade. J. Biol. Chem.
276:21938–21942.
36. May, J. M., and C. de Haen. 1979. Insulin-stimulated intracellular hydrogen
peroxide production in rat epididymal fat cells. J. Biol. Chem. 254:2214–
2220.
37. Meng, T. C., T. Fukada, and N. K. Tonks. 2002. Reversible oxidation and
inactivation of protein tyrosine phosphatases in vivo. Mol. Cell 9:387–399.
38. Mukherjee, S. P., and W. S. Lynn. 1977. Reduced nicotinamide adenine
dinucleotide phosphate oxidase in adipocyte plasma membrane and its ac-
tivation by insulin. Possible role in the hormone’s effects on adenylate cyclase
and the hexose monophosphate shunt. Arch. Biochem. Biophys. 184:69–76.
39. Nisimoto, Y., H. Otsuka-Murakami, and D. J. Lambeth. 1995. Reconstitu-
tion of flavin-depleted neutrophil flavocytochrome b558 with 8-mercapto-
FAD and characterization of the flavin-reconstituted enzyme. J. Biol. Chem.
270:16428–16434.
40. Orlicky, D. J., and J. Schaack. 2001. Adenovirus transduction of 3T3-L1
cells. J. Lipid Res. 42:460–466.
41. Rhee, S. G., Y. S. Bae, S. R. Lee, and J. Kwon. 2000. Hydrogen peroxide: a
key messenger that modulates protein phosphorylation through cysteine
oxidation. Sci. STKE 2000:E1.
42. Saltiel, A. R., and C. R. Kahn. 2001. Insulin signalling and the regulation of
glucose and lipid metabolism. Nature 414:799–806.
43. Shaw, M., P. Cohen, and D. R. Alessi. 1998. The activation of protein kinase
B by H2O2 or heat shock is mediated by phosphoinositide 3-kinase and not
by mitogen-activated protein kinase-activated protein kinase-2. Biochem. J.
336:241–246.
44. Tonks, N. K. 2003. PTP1B: from the sidelines to the front lines! FEBS Lett.
546:140–148.
45. White, M. F. 2002. IRS proteins and the common path to diabetes. Am. J.
Physiol. Endocrinol. Metab. 283:E413–E422.
46. Woo, H. A., H. Z. Chae, S. C. Hwang, K. S. Yang, S. W. Kang, K. Kim, and
S. G. Rhee. 2003. Reversing the inactivation of peroxiredoxins caused by
cysteine sulfinic acid formation. Science 300:653–656.
47. Zhu, L., A. Zilbering, X. Wu, K. Mahadev, J. I. Joseph, S. Jabbour, W. Deeb,
and B. J. Goldstein. 2001. Use of an anaerobic environment to preserve the
endogenous activity of protein-tyrosine phosphatases isolated from intact
cells. FASEB J. 15:1637–1639.
1854 MAHADEV ET AL. MOL. CELL. BIOL.
 at Thom
as Jefferson Univ on Decem
ber 5, 2007 
m
cb.asm
.org
D
ow
nloaded from
 
